{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T13:33:20Z","timestamp":1676986400736},"reference-count":21,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/crd.0000000000000051","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T05:45:59Z","timestamp":1421041559000},"page":"148-152","source":"Crossref","is-referenced-by-count":3,"title":["Omega-3-Carboxylic Acid (Epanova) for Hypertriglyceridemia"],"prefix":"10.1097","volume":"23","author":[{"given":"Alan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sum","family":"Lam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210203","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/archinternmed.2008.599","article-title":"Hypertriglyceridemia and its pharmacologic treatment among US adults.","volume":"169","author":"Ford","year":"2009","journal-title":"Arch Intern Med"},{"key":"R2-6-20210203","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association.","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"R3-6-20210203","doi-asserted-by":"crossref","first-page":"7B","DOI":"10.1016\/S0002-9149(98)00031-9","article-title":"Hypertriglyceridemia as a cardiovascular risk factor.","volume":"81","author":"Austin","year":"1998","journal-title":"Am J Cardiol"},{"key":"R4-6-20210203","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1161\/CIRCULATIONAHA.106.637793","article-title":"Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies.","volume":"115","author":"Sarwar","year":"2007","journal-title":"Circulation"},{"key":"R5-6-20210203","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/ajg.2013.218","article-title":"American College of Gastroenterology. American College of Gastroenterology guideline: management of acute pancreatitis.","volume":"108","author":"Tenner","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"R8-6-20210203","doi-asserted-by":"crossref","first-page":"2969","DOI":"10.1210\/jc.2011-3213","article-title":"Endocrine society. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.","volume":"97","author":"Berglund","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R9-6-20210203","first-page":"681","article-title":"Overview of omega-3 fatty acid therapies.","volume":"38","author":"Bradberry","year":"2013","journal-title":"P T"},{"key":"R12-6-20210203","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1056\/NEJM199704103361502","article-title":"Fish consumption and the 30-year risk of fatal myocardial infarction.","volume":"336","author":"Daviglus","year":"1997","journal-title":"N Engl J Med"},{"key":"R13-6-20210203","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.287.14.1815","article-title":"Fish and omega-3 fatty acid intake and risk of coronary heart disease in women.","volume":"287","author":"Hu","year":"2002","journal-title":"JAMA"},{"key":"R14-6-20210203","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0002-9343(01)01114-7","article-title":"N-3 polyunsaturated fatty acids in coronary heart disease: a meta-analysis of randomized controlled trials.","volume":"112","author":"Bucher","year":"2002","journal-title":"Am J Med"},{"key":"R15-6-20210203","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/bmj.38755.366331.2F","article-title":"Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review.","volume":"332","author":"Hooper","year":"2006","journal-title":"BMJ"},{"key":"R17-6-20210203","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1001\/2012.jama.11374","article-title":"Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.","volume":"308","author":"Rizos","year":"2012","journal-title":"JAMA"},{"key":"R19-6-20210203","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00043798-199710000-00011","article-title":"Safety and efficacy of Omacor in severe hypertriglyceridemia.","volume":"4","author":"Harris","year":"1997","journal-title":"J Cardiovasc Risk"},{"key":"R20-6-20210203","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jacl.2011.10.018","article-title":"Effects of eicosapentaenoic acid and docosahexaenoic acid on low-density lipoprotein cholesterol and other lipids: a review.","volume":"6","author":"Jacobson","year":"2012","journal-title":"J Clin Lipidol"},{"key":"R22-6-20210203","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.jacl.2012.07.001","article-title":"Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on lipoprotein particle concentration and size in patients with very high triglyceride levels (the MARINE study).","volume":"6","author":"Bays","year":"2012","journal-title":"J Clin Lipidol"},{"key":"R23-6-20210203","first-page":"485","article-title":"Icosapent ethyl for the treatment of severe hypertriglyceridemia.","volume":"10","author":"Fares","year":"2014","journal-title":"Ther Clin Risk Manag"},{"key":"R25-6-20210203","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jacl.2012.01.002","article-title":"A novel omega-3 free fatty acid formulation has dramatically improved bioavailability during a low-fat diet compared with omega-3-acid ethyl esters: the ECLIPSE (Epanova() compared to Lovaza() in a pharmacokinetic single-dose evaluation) study.","volume":"6","author":"Davidson","year":"2012","journal-title":"J Clin Lipidol"},{"key":"R26-6-20210203","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jacl.2013.10.003","article-title":"Omega-3 free fatty acids for the treatment of severe hypertriglyceridemia: the EpanoVa fOr Lowering Very high triglyceridEs (EVOLVE) trial.","volume":"8","author":"Kastelein","year":"2014","journal-title":"J Clin Lipidol"},{"key":"R28-6-20210203","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.amjcard.2010.11.008","article-title":"Prevalence of severe (500 to 2,000mgdl) hypertriglyceridemia in United States adults.","volume":"107","author":"Christian","year":"2011","journal-title":"Am J Cardiol"},{"key":"R29-6-20210203","doi-asserted-by":"crossref","first-page":"243","DOI":"10.3945\/ajcn.110.003871","article-title":"Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.","volume":"93","author":"Skulas-Ray","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"R30-6-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.plefa.2013.07.005","article-title":"Icosapent ethyl, a pure EPA omega-3 fatty acid: effects on plasma and red blood cell fatty acids in patients with very high triglyceride levels (results from the MARINE study).","volume":"89","author":"Braeckman","year":"2013","journal-title":"Prostaglandins Leukot Essent Fatty Acids"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000051","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:49:30Z","timestamp":1620949770000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045415-201505000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":21,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000051","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}